reported the immune regulatory function of TLR4 signaling in AD murine model induced by repeated epicutaneous application of a hapten, TLR4-deficient mice showed more severe AD symptoms and higher expression levels of inflammatory cytokines than wild-type mice after hapten challenge (63). This evidence concerns the gene TLR4 and Alzheimer disease.